Herpes_NN Simplex_NP Virus_NP Type_NP 2_CD Virion_NP Host_NP Shutoff_NP Protein_NP Regulates_NP Alpha/Beta_NP Interferon_NP but_CC Not_RB Adaptive_JJ Immune_NP Responses_NNS during_IN Primary_NP Infection_NP In_IN Vivo_NP The_DT herpes_NN simplex_JJ virus_NN (_( HSV_NP )_) virion_NN host_NN shutoff_NN (_( vhs_NNS )_) protein_NN ,_, the_DT product_NN of_IN the_DT UL41_JJ (_( vhs_NNS )_) gene_NN ,_, is_VBZ an_DT important_JJ determinant_NN of_IN HSV_NP virulence_NN ._SENT vhs_NP has_VBZ been_VBN implicated_VBN in_IN HSV_NP interference_NN with_IN host_NN antiviral_JJ immune_JJ responses_NNS ,_, down-regulating_VBG expression_NN of_IN major_JJ histocompatibility_NN complex_NN molecules_NNS to_TO help_VB HSV_NP evade_VB host_NN adaptive_JJ immunity_NN ._SENT The_DT severe_JJ attenuation_NN of_IN vhs-deficient_JJ viruses_NNS in_IN vivo_RB could_MD reflect_VB their_PP$ inability_NN to_TO escape_VB immune_JJ detection_NN ._SENT To_TO test_VB this_DT hypothesis_NN ,_, BALB/c_NP or_CC congenic_JJ SCID_NN mice_NNS were_VBD infected_VBN intravaginally_RB (_( i.vag_NP ._SENT )_) with_IN the_DT HSV_NP type_NN 2_CD (_( HSV-2_NP )_) vhs_VBZ null_JJ mutant_JJ 333d41_JJ or_CC the_DT vhs_NNS rescue_NN virus_NN 333d41R_NN ._SENT vhs-deficient_JJ virus_NN remained_VBD severely_RB attenuated_VBN in_IN SCID_NN mice_NNS compared_VBN with_IN rescue_NN virus_NN ,_, indicating_VBG that_DT vhs_NNS regulation_NN of_IN adaptive_JJ immune_JJ responses_NNS does_VBZ not_RB influence_VB HSV_NP pathogenesis_NN during_IN acute_JJ infection_NN ._SENT Innate_JJ antiviral_JJ effectors_NNS remain_VBP intact_JJ in_IN SCID_NN mice_NNS ;_: prominent_JJ among_IN these_DT is_VBZ alpha/beta_NN interferon_NN (_( IFN-alpha/beta_NP )_) ._SENT The_DT attenuation_NN of_IN HSV-2_NP vhs_NNS mutants_NNS could_MD reflect_VB their_PP$ failure_NN to_TO suppress_VB IFN-alpha/beta-mediated_JJ antiviral_JJ activity_NN ._SENT To_TO test_VB this_DT hypothesis_NN ,_, 129_CD and_CC congenic_JJ IFN-alpha/beta_NP receptor-deficient_NN (_( IFN-alpha/betaR-/-_NP )_) mice_NNS were_VBD infected_VBN i.vag_NN ._SENT with_IN wild-type_NN virus_NN ,_, vhs_VBZ null_JJ mutants_NNS 333-vhsB_JJ or_CC 333d41_JJ ,_, or_CC the_DT vhs_NNS rescue_NN virus_NN 333d41R_NN ._SENT Whereas_IN vhs-deficient_JJ viruses_NNS showed_VBD greatly_RB reduced_VBN replication_NN in_IN the_DT genital_JJ mucosa_NN of_IN 129_CD mice_NNS compared_VBN with_IN wild-type_NN or_CC vhs_NNS rescue_NN viruses_NNS ,_, they_PP were_VBD restored_VBN to_TO nearly_RB wild-type_JJ levels_NNS of_IN replication_NN in_IN IFN-alpha/betaR-/-_NP mice_NNS over_IN the_DT first_JJ 2_CD days_NNS postinfection_NN ._SENT Only_JJ wild-type_NN and_CC vhs_NNS rescue_NN viruses_NNS caused_VBD severe_JJ genital_JJ disease_NN and_CC hind_JJ limb_NN paralysis_NN in_IN 129_CD mice_NNS ,_, but_CC infection_NN of_IN IFN-alpha/betaR-/-_NP mice_NNS restored_VBD the_DT virulence_NN of_IN vhs-deficient_JJ viruses_NNS ._SENT vhs-deficient_JJ viruses_NNS replicated_VBN as_RB vigorously_RB as_IN wild-type_NN and_CC rescue_NN viruses_NNS in_IN the_DT nervous_JJ systems_NNS of_IN IFN-alpha/betaR-/-_NN mice_NNS ._SENT Restoration_NN was_VBD specific_JJ for_IN the_DT vhs_NNS mutation_NN ,_, because_IN thymidine_NN kinase-deficient_NN HSV-2_NP did_VBD not_RB regain_VB virulence_NN or_CC the_DT capacity_NN to_TO replicate_VB in_IN the_DT nervous_JJ systems_NNS of_IN IFN-alpha/betaR-/-_NN mice_NNS ._SENT Furthermore_RB ,_, the_DT defect_NN in_IN the_DT IFN-alpha/beta_NP response_NN was_VBD required_VBN for_IN restoration_NN of_IN vhs-deficient_JJ virus_NN replication_NN and_CC virulence_NN ,_, but_CC the_DT IFN-alpha/beta-stimulated_JJ protein_NN kinase_NN R_NN pathway_NN was_VBD not_RB involved_VBN ._SENT Finally_RB ,_, vhs_NNS of_IN HSV-2_NP has_VBZ a_DT unique_JJ capacity_NN to_TO interfere_VB with_IN the_DT IFN-alpha/beta_NP response_NN in_IN vivo_RB ,_, because_IN an_DT HSV-1_JJ vhs_NNS null_JJ mutant_NN did_VBD not_RB recover_VB replication_NN and_CC virulence_NN after_IN i.vag_NN ._SENT inoculation_NN into_IN IFN-alpha/betaR-/-_NP mice_NNS ._SENT These_DT results_NNS indicate_VBP that_IN vhs_NN plays_VBZ an_DT important_JJ role_NN early_RB in_IN HSV-2_JJ pathogenesis_NN in_IN vivo_JJ by_IN interfering_VBG with_IN the_DT IFN-alpha/beta-mediated_JJ antiviral_JJ response_NN ._SENT Herpes_NN simplex_JJ virus_NN types_NNS 1_CD and_CC 2_CD (_( HSV-1_NP and_CC HSV-2_NP )_) are_VBP ubiquitous_JJ human_JJ pathogens_NNS that_WDT cause_VBP a_DT variety_NN of_IN serious_JJ diseases_NNS ._SENT Primary_JJ HSV_NP infections_NNS typically_RB initiate_VBP at_IN mucosal_JJ surfaces_NNS ,_, where_WRB lytic_JJ replication_NN in_IN epithelial_JJ cells_NNS generates_VBZ mucosal_JJ lesions_NNS ._SENT Peripheral_JJ replication_NN amplifies_VBZ the_DT virus_NN load_NN and_CC increases_NNS uptake_NN of_IN virus_NN into_IN sensory_JJ nerve_NN termini_NNS ._SENT Establishment_NN of_IN latent_JJ infections_NNS in_IN sensory_JJ neurons_NNS secures_VBZ shelter_NN for_IN the_DT virus_NN throughout_IN the_DT life_NN of_IN the_DT host_NN ._SENT Periodic_JJ reactivations_NNS result_NN in_IN disease_NN recurrence_NN and_CC provide_VB an_DT opportunity_NN for_IN transmission_NN to_TO new_JJ hosts_NNS ._SENT The_DT virion_NN host_NN shutoff_NN (_( vhs_NNS )_) protein_NN of_IN HSV_NP plays_VBZ a_DT significant_JJ role_NN in_IN promoting_VBG pathogenesis_NN at_IN the_DT cell_NN and_CC organismal_JJ levels_NNS ._SENT In_IN the_DT infected_JJ cell_NN ,_, vhs_NP possesses_VBZ both_DT endo-_NN and_CC exonuclease_NN activity_NN and_CC mediates_VBZ the_DT rapid_JJ shutoff_NN of_IN protein_NN synthesis_NN via_IN degradation_NN of_IN both_DT cellular_JJ and_CC viral_JJ mRNAs_NNS ._SENT As_IN a_DT component_NN of_IN the_DT virion_NN tegument_NN ,_, vhs_NNS is_VBZ released_VBN directly_RB into_IN the_DT cytosol_NN and_CC can_MD immediately_RB exert_VB its_PP$ effects_NNS on_IN the_DT newly_RB infected_JJ cell_NN ._SENT Cellular_JJ mRNAs_NNS are_VBP almost_RB completely_RB degraded_VBN within_IN 6_CD h_NN of_IN infection_NN with_IN HSV-1_NP ,_, and_CC within_IN just_RB 2_CD h_NN by_IN HSV-2_NP ._SENT The_DT activity_NN of_IN HSV-2_NP vhs_NNS is_VBZ also_RB approximately_RB 40-fold_JJ stronger_JJR than_IN that_DT of_IN HSV-1_NP ._SENT In_IN vivo_RB ,_, vhs_NNS null_JJ mutants_NNS of_IN HSV-1_NP and_CC HSV-2_NP are_VBP profoundly_RB attenuated_VBN ,_, implicating_VBG vhs_NNS as_IN a_DT virulence_NN factor_NN that_WDT helps_VBZ HSV_NP establish_VB robust_JJ infection_NN ._SENT HSV-1_JJ lacking_JJ vhs_NNS activity_NN replicates_VBZ to_TO 1,000-fold-lower_JJ titers_NNS in_IN the_DT cornea_NN ,_, trigeminal_JJ ganglia_NNS ,_, and_CC brain_NN of_IN mice_NNS than_IN wild-type_NN virus_NN and_CC has_VBZ impaired_VBN capacity_NN to_TO enter_VB the_DT central_JJ nervous_JJ system_NN ,_, establish_VB latency_NN ,_, and_CC undergo_VBP reactivation_NN (_( -_: )_) ._SENT vhs-deficient_JJ HSV-2_NP strains_NNS (_( 333-vhsB_JJ or_CC 333d41_JJ )_) also_RB replicate_VB much_RB less_RBR efficiently_RB than_IN wild-type_NN virus_NN in_IN the_DT genital_JJ mucosa_NN and_CC nervous_JJ tissue_NN of_IN mice_NNS and_CC cause_VB less_JJR disease_NN ._SENT vhs_NP has_VBZ been_VBN implicated_VBN in_IN down-regulating_VBG major_JJ histocompatibility_NN complex_NN (_( MHC_NP )_) class_NN I_PP and_CC class_VB II_NP molecules_NNS ._SENT This_DT activity_NN has_VBZ functional_JJ implications_NNS because_IN it_PP is_VBZ associated_VBN with_IN reduced_VBN cytotoxic_JJ T-lymphocyte_NN recognition_NN of_IN HSV-infected_JJ cells_NNS ._SENT Thus_RB ,_, vhs-deficient_JJ viruses_NNS may_MD be_VB unable_JJ to_TO evade_VB critical_JJ adaptive_JJ immune_JJ responses_NNS during_IN acute_JJ infection_NN ,_, leading_VBG to_TO their_PP$ attenuation_NN ._SENT Alternatively_RB ,_, the_DT attenuation_NN of_IN HSV-1_NP and_CC HSV-2_NP vhs_NNS null_JJ mutants_NNS within_IN 24_CD to_TO 48_CD h_NN postinfection_NN (_( -_: )_) suggests_VBZ a_DT pivotal_JJ role_NN for_IN mediators_NNS of_IN innate_JJ immunity_NN in_IN controlling_VBG acute_JJ infection_NN ._SENT A_DT key_JJ mediator_NN of_IN innate_JJ antiviral_JJ immunity_NN to_TO virus_NN infection_NN is_VBZ the_DT alpha/beta_NN interferon_NN (_( IFN-alpha/beta_NP )_) response_NN ._SENT The_DT many_JJ subtypes_NNS of_IN IFN-alpha_NP and_CC IFN-beta_NP are_VBP released_VBN from_IN infected_JJ cells_NNS and_CC bind_NN to_TO a_DT single_JJ IFN-alpha/beta_NP receptor_NN (_( IFN-alpha/betaR_NP )_) ._SENT Receptor-mediated_JJ signal_NN transduction_NN stimulates_VBZ expression_NN of_IN numerous_JJ IFN-stimulated_JJ genes_NNS whose_WP$ products_NNS can_MD interfere_VB with_IN viral_JJ replication_NN by_IN disrupting_VBG macromolecular_JJ synthesis_NN ._SENT HSV-1_JJ in_IN culture_NN is_VBZ relatively_RB insensitive_JJ to_TO the_DT effects_NNS of_IN IFN-alpha/beta_NP ,_, being_VBG reduced_VBN 2-_CD to_TO 5-fold_NN for_IN replication_NN ,_, compared_VBN to_TO a_DT more_JJR than_IN 10,000-fold_NN reduction_NN for_IN vesicular_JJ stomatitis_NN virus_NN ._SENT In_IN addition_NN ,_, HSV-1_JJ virulence_NN is_VBZ not_RB substantially_RB increased_VBN in_IN mice_NNS lacking_VBG the_DT IFN-alpha/betaR_NP (_( IFN-alpha/betaR-/-_NP )_) ,_, suggesting_VBG that_IN HSV_NP has_VBZ a_DT means_NN to_TO effectively_RB counter_VB the_DT IFN-alpha/beta_NP response_NN ._SENT Determinants_NNS of_IN HSV-1_NP IFN_NP resistance_NN have_VBP been_VBN mapped_VBN to_TO ICP0_NP ,_, Us11_NP ,_, and_CC gamma34.5_NN ._SENT Each_DT of_IN these_DT proteins_NNS has_VBZ been_VBN confirmed_VBN as_IN a_DT contributor_NN to_TO HSV-1_JJ virulence_NN (_( ,_, ,_, ;_: S._NP Ward_NP and_CC D._NP Leib_NP ,_, personal_JJ communication_NN )_) ._SENT Evidence_NN for_IN HSV-1_JJ vhs_NNS as_IN an_DT additional_JJ inhibitor_NN of_IN the_DT IFN-alpha/beta_NP response_NN is_VBZ controversial_JJ and_CC is_VBZ not_RB borne_VBN out_RP in_IN vivo_RB ._SENT Replication_NN of_IN an_DT HSV-1_JJ vhs_NNS null_JJ mutant_NN is_VBZ slightly_RB elevated_JJ and_CC prolonged_JJ in_IN the_DT corneas_NNS of_IN IFN-alpha/betaR-/-_NN mice_NNS compared_VBN to_TO wild-type_NN mice_NNS ._SENT However_RB ,_, the_DT titer_NN of_IN vhs-deficient_JJ HSV-1_NP is_VBZ 1,000-fold_NN lower_JJR than_IN that_IN of_IN wild-type_NN virus_NN at_IN all_DT times_NNS in_IN IFN-alpha/betaR-/-_NN mice_NNS ,_, indicating_VBG that_IN HSV-1_JJ vhs_NNS does_VBZ not_RB play_VB a_DT significant_JJ role_NN in_IN counteracting_VBG IFN-alpha/betaR_NP signaling_VBG in_IN vivo_RB ._SENT Mediators_NNS of_IN IFN_NP resistance_NN in_IN HSV-2_NP have_VBP not_RB been_VBN well_RB characterized_VBN ,_, but_CC several_JJ observations_NNS suggest_VBP that_IN vhs_NNS may_MD contribute_VB in_IN this_DT case_NN ._SENT Genetic_JJ studies_NNS have_VBP mapped_VBN IFN_NP resistance_NN to_TO a_DT 7.4-kb_JJ region_NN of_IN the_DT HSV-2_NP genome_NN that_WDT contains_VBZ the_DT vhs_NNS gene_NN and_CC portions_NNS of_IN two_CD flanking_VBG genes_NNS ._SENT Another_DT genetic_JJ locus_NN influencing_VBG HSV-2_NP resistance_NN to_TO IFN-alpha/beta_NP has_VBZ been_VBN mapped_VBN 60_CD kb_NN distant_JJ from_IN the_DT vhs_NNS locus_NN ._SENT This_DT region_NN contains_VBZ the_DT UL13_NP viral_JJ kinase_NN ,_, which_WDT influences_VBZ either_DT vhs_NNS synthesis_NN or_CC activity_NN ._SENT In_IN addition_NN to_TO genetic_JJ evidence_NN ,_, HSV-2_NP is_VBZ even_RB more_RBR resistant_JJ to_TO IFN-alpha/beta_NP in_IN vitro_NP than_IN HSV-1_NP ,_, and_CC HSV-2_NP vhs_NNS activity_NN is_VBZ more_RBR potent_JJ than_IN that_IN of_IN HSV-1_JJ vhs_NNS (_( -_: ,_, )_) ._SENT These_DT observations_NNS led_VBD us_PP to_TO investigate_VB whether_IN HSV-2_JJ vhs_NNS interferes_VBZ with_IN the_DT host_NN IFN-alpha/beta_NP response_NN ._SENT Here_RB we_PP use_VBP a_DT mouse_NN model_NN of_IN genital_JJ infection_NN with_IN HSV-2_NP to_TO examine_VB the_DT role_NN of_IN vhs_NNS in_IN countering_VBG host_NN adaptive_JJ immune_JJ and_CC innate_JJ responses_NNS to_TO primary_JJ infection_NN ._SENT Cells_NNS and_CC viruses_NNS ._SENT |_SYM Vero_NP cells_NNS were_VBD maintained_VBN in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP 's_POS medium_NN supplemented_VBD with_IN 3_CD %_NN newborn_NN and_CC 3_CD %_NN fetal_JJ calf_NN serum_NN ._SENT SB5_NP ,_, a_DT plaque-purified_JJ stock_NN of_IN HSV-2_NP strain_NN 333_CD ,_, was_VBD obtained_VBN from_IN the_DT American_NP Type_NP Culture_NP Collection_NP (_( VR-2546_NP )_) ._SENT HSV-1_JJ strain_NN UL41NHB_NP and_CC HSV-2_NP strain_VBP 333d41_JJ were_VBD obtained_VBN from_IN David_NP Leib_NP ._SENT The_DT vhs_NNS open_VBP reading_NN frame_NN (_( ORF_NP )_) in_IN UL41NHB_NP is_VBZ disrupted_VBN by_IN insertion_NN of_IN the_DT Escherichia_NP coli_NNS lacZ_NN gene_NN under_IN the_DT control_NN of_IN the_DT human_JJ cytomegalovirus_NN immediate-early_NN 1_CD (_( IE1_NP )_) promoter_NN at_IN a_DT ScaI_NP site_NN ._SENT 333d41_JJ has_VBZ a_DT targeted_JJ deletion_NN within_IN the_DT UL41_JJ gene_NN between_IN two_CD XcmI_NP sites_NNS ,_, resulting_VBG in_IN a_DT 939-bp_NN excision_NN and_CC complete_JJ lack_NN of_IN vhs_NNS activity_NN ._SENT 333d41R_NP was_VBD constructed_VBN by_IN cotransfecting_VBG full-length_JJ 333d41_JJ DNA_NN with_IN p41SB5-B_NN ,_, a_DT plasmid_NN containing_VBG a_DT BglII_NP genomic_JJ fragment_NN of_IN HSV-2_NP 333_CD that_WDT includes_VBZ the_DT UL41_JJ gene_NN ._SENT Briefly_RB ,_, 1_CD mug_NN of_IN each_DT DNA_NN mixed_VBN with_IN Lipofectamine_NP (_( Invitrogen_NP )_) was_VBD used_VBN to_TO transfect_JJ Vero_NP cells_NNS ._SENT Viral_JJ progeny_NN were_VBD screened_VBN by_IN PCR_NP for_IN the_DT deletion_NN within_IN vhs_NNS by_IN using_VBG the_DT primers_NNS 5'-GCG_NN TCC_NP AAC_NP CGA_NP TAA_NP ATC_NP AAG_NP C-3'(forward)_NP and_CC 5'-TTA_NP CCC_NP AAA_NP AGT_NP CCC_NP TGT_NP TCC_NP C-3_NP '_'' (_( reverse_JJ )_) ,_, with_IN 30_CD cycles_NNS of_IN 95C_NN for_IN 30_CD s_NNS ,_, 66.1C_JJ for_IN 30_CD s_NNS ,_, and_CC 72C_NP for_IN 60_CD s._JJ PCR_NP products_NNS were_VBD analyzed_VBN on_IN agarose_JJ gels_NNS stained_VBN with_IN ethidium_NN bromide_NN ._SENT Isolates_NNS were_VBD plaque_NN purified_VBN three_CD times_NNS ,_, and_CC identity_NN of_IN the_DT rescue_NN virus_NN was_VBD confirmed_VBN by_IN Southern_NP blot_NN analysis_NN using_VBG a_DT BamHI_NP digest_NN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT RNase_NP activity_NN of_IN 333d41R_NP was_VBD confirmed_VBN by_IN Northern_JJ blot_NN analysis_NN in_IN an_DT mRNA_NN degradation_NN assay_NN described_VBD elsewhere_RB and_CC was_VBD identical_JJ to_TO that_DT of_IN SB5_NP (_( data_NN not_RB shown_VBN )_) ._SENT HSV-2_JJ strains_NNS 333-vhsB_JJ and_CC DeltaTK-_NP were_VBD the_DT generous_JJ gifts_NNS of_IN Jim_NP Smiley_NP ._SENT 333-vhsB_JJ contains_VBZ a_DT cassette_NN consisting_VBG of_IN the_DT ICP6_NP promoter_NN driving_VBG the_DT lacZ_NN gene_NN ._SENT The_DT cassette_NN was_VBD inserted_VBN at_IN codon_NN 30_CD of_IN the_DT vhs_NP ORF_NP ,_, disrupting_VBG the_DT UL41_JJ gene_NN ._SENT DeltaTK-_NP contains_VBZ a_DT 180-bp_JJ deletion_NN in_IN the_DT thymidine_NN kinase_NN (_( tk_NN )_) ORF_NP of_IN strain_NN 333_CD that_WDT inhibits_VBZ tk_NN activity_NN ._SENT Cell_NN lysate_NN stocks_NNS of_IN each_DT strain_NN were_VBD prepared_VBN as_IN previously_RB described_VBN ._SENT Titers_NNS of_IN virus_NN stocks_NNS were_VBD determined_VBN by_IN simultaneous_JJ titration_NN on_IN Vero_NP cell_NN monolayers_NNS to_TO ensure_VB equivalent_JJ doses_NNS of_IN virus_NN in_IN the_DT inocula_NNS ._SENT Animals_NNS and_CC infections_NNS ._SENT |_SYM BALB/c_NP mice_NNS were_VBD purchased_VBN from_IN the_DT National_NP Cancer_NP Institute_NP (_( Frederick_NP ,_, Md._NP )_) ._SENT CB-17.SCID_NP mice_NNS were_VBD purchased_VBN from_IN Taconic_NP (_( Germantown_NP ,_, N.Y._NP )_) ._SENT IFN-alpha/betaR-/-_NP and_CC congenic_NP 129_CD [_SYM 129Sv(ev)_NP ]_SYM mice_NNS were_VBD generously_RB provided_VBN by_IN Michel_NP Aguet_NP and_CC were_VBD obtained_VBN from_IN Skip_NP Virgin_NP ._SENT Protein_NN kinase_NN R-deficient_NP (_( PKR-/-_NP )_) mice_NNS on_IN the_DT 129_CD background_NN were_VBD generously_RB provided_VBN by_IN Bob_NP Silverman_NP and_CC were_VBD obtained_VBN from_IN Skip_NP Virgin_NP ._SENT 129_CD ,_, IFN-alpha/betaR-/-_NP ,_, and_CC PKR-/-_NP mice_NNS were_VBD bred_VBN and_CC housed_VBN in_IN the_DT Department_NP of_IN Comparative_NP Medicine_NP ,_, Saint_NP Louis_NP University_NP School_NP of_IN Medicine_NP ._SENT All_DT mice_NNS were_VBD maintained_VBN in_IN accordance_NN with_IN institutional_JJ and_CC Public_NP Health_NP Service_NP guidelines_NNS and_CC were_VBD used_VBN at_IN 6_CD weeks_NNS of_IN age_NN ._SENT Vaginal_JJ swab_NN and_CC neural_JJ tissue_NN titers_NNS ._SENT |_SYM Vaginal_NP vaults_NNS were_VBD swabbed_VBN twice_RB at_IN 10_CD h_NN and_CC days_NNS 1_CD through_IN 4_CD postinfection_NN using_VBG type_NN 1_CD calcium_NN alginate_NN swabs_NNS (_( Puritan_NP )_) ._SENT The_DT swabs_NNS were_VBD placed_VBN together_RB into_IN vials_NNS containing_VBG 1_CD ml_NN of_IN phosphate-buffered_JJ saline_NN and_CC stored_VBD at_IN -80C_NN ._SENT At_IN 6_CD days_NNS postinfection_NN ,_, mice_NNS were_VBD sacrificed_VBN and_CC the_DT spinal_JJ cord_NN ,_, brainstem_NN ,_, and_CC brain_NN were_VBD dissected_VBN ,_, placed_VBN in_IN microcentrifuge_NN tubes_NNS containing_VBG phosphate-buffered_JJ saline_NN and_CC 1-mm_JJ glass_NN beads_NNS ,_, and_CC stored_VBD at_IN -80C_NN ._SENT Thawed_VBN tissues_NNS were_VBD disrupted_VBN using_VBG a_DT Mini_NP BeadBeater_NP 8_CD (_( Biospec_NP Products_NPS )_) ._SENT Viral_JJ titers_NNS in_IN swab_NN samples_NNS and_CC tissues_NNS were_VBD determined_VBN by_IN standard_JJ plaque_NN assay_NN ._SENT Disease_NN scores_NNS ._SENT |_SYM Severity_NP of_IN genital_JJ and_CC neurologic_JJ disease_NN was_VBD assessed_VBN on_IN days_NNS 2_CD through_IN 6_CD postinfection_NN using_VBG the_DT following_VBG scale_NN :_: 0_CD ,_, no_DT signs_NNS ;_: 1_LS ,_, mild_JJ erythema_NN and_CC edema_NN of_IN the_DT external_JJ genitalia_NN ;_: 2_LS ,_, moderate_JJ erythema_NN and_CC edema_NN of_IN the_DT external_JJ genitalia_NN ;_: 3_LS ,_, severe_JJ erythema_NN and_CC edema_NN of_IN the_DT external_JJ genitalia_NN with_IN presence_NN of_IN lesions_NNS ;_: 4_LS ,_, bilateral_JJ hind_JJ limb_NN paralysis_NN ;_: 5_LS ,_, death_NN ._SENT Statistics_NNS ._SENT |_SYM Significance_NP of_IN difference_NN in_IN viral_JJ titer_NN between_IN groups_NNS on_IN individual_JJ days_NNS was_VBD determined_VBN by_IN the_DT t_NN test_NN ._SENT The_DT nonparametric_JJ Kruskall-Wallis_NP test_NN was_VBD used_VBN to_TO determine_VB significance_NN of_IN difference_NN in_IN disease_NN scores_NNS between_IN groups_NNS on_IN individual_JJ days_NNS ._SENT vhs-deficient_JJ mutants_NNS of_IN HSV-1_NP and_CC HSV-2_NP replicate_VB poorly_RB compared_VBN to_TO wild-type_NN virus_NN in_IN the_DT mouse_NN cornea_NN and_CC genital_JJ mucosa_NN ,_, respectively_RB ._SENT They_PP also_RB cause_VBP minimal_JJ disease_NN and_CC have_VBP reduced_VBN capacity_NN to_TO replicate_VB in_IN the_DT nervous_JJ system_NN ._SENT We_PP reasoned_VBD that_IN if_IN adaptive_JJ immune_JJ responses_NNS are_VBP responsible_JJ for_IN the_DT attenuation_NN of_IN vhs-deficient_JJ viruses_NNS ,_, then_RB replication_NN and_CC virulence_NN should_MD be_VB restored_VBN in_IN mice_NNS lacking_VBG adaptive_JJ immune_JJ functions_NNS ._SENT To_TO test_VB this_DT hypothesis_NN ,_, BALB/c_NP and_CC congenic_JJ CB-17.SCID_NP mice_NNS were_VBD infected_VBN i.vag_NN ._SENT with_IN 2_CD x_SYM 106_CD PFU_NP of_IN the_DT vhs-deficient_JJ mutant_JJ 333d41_JJ or_CC the_DT vhs_NNS rescue_NN virus_NN ,_, 333d41R_NP ._SENT Titers_NNS of_IN vhs_NNS rescue_NN virus_NN collected_VBN from_IN daily_JJ vaginal_JJ swabs_NNS of_IN BALB/c_NP and_CC SCID_NN mice_NNS were_VBD significantly_RB higher_JJR than_IN those_DT of_IN 333d41_JJ on_IN days_NNS 2_CD to_TO 4_CD postinfection_NN ._SENT Correspondingly_RB ,_, BALB/c_NP mice_NNS infected_VBN with_IN vhs_NNS rescue_NN virus_NN rapidly_RB developed_VBD severe_JJ genital_JJ inflammation_NN ,_, and_CC lesions_NNS were_VBD present_JJ by_IN 6_CD days_NNS postinfection_NN ._SENT Inflammation_NN provoked_VBD by_IN 333d41_JJ infection_NN was_VBD comparatively_RB moderate_JJ ._SENT The_DT same_JJ dichotomy_NN was_VBD observed_VBN in_IN SCID_NN mice_NNS ,_, where_WRB rescue_NN virus_NN caused_VBD pronounced_JJ inflammation_NN but_CC vhs-deficient_JJ virus_NN did_VBD not_RB ._SENT Interestingly_RB ,_, genital_JJ inflammation_NN was_VBD more_RBR severe_JJ in_IN BALB/c_NP mice_NNS than_IN SCID_NN mice_NNS ,_, suggesting_VBG an_DT immunopathologic_JJ component_NN to_TO the_DT inflammatory_JJ response_NN ._SENT Virus_NN titer_NN in_IN the_DT nervous_JJ system_NN was_VBD determined_VBN on_IN day_NN 6_CD postinfection_NN ._SENT vhs_NNS rescue_NN virus_NN replicated_VBN to_TO high_JJ titers_NNS in_IN the_DT spinal_JJ cord_NN of_IN BALB/c_NP mice_NNS and_CC ,_, as_IN anticipated_VBN ,_, levels_NNS of_IN 333d41_JJ were_VBD much_RB lower_JJR ._SENT Brainstem_NN and_CC brain_NN tissue_NN of_IN BALB/c_NP mice_NNS contained_VBD less_JJR rescue_NN virus_NN ,_, but_CC 333d41_JJ could_MD not_RB be_VB detected_VBN ._SENT In_IN SCID_NN mice_NNS ,_, rescue_NN virus_NN replicated_VBN to_TO high_JJ titer_NN in_IN the_DT central_JJ nervous_JJ system_NN ,_, but_CC titers_NNS of_IN 333d41_JJ remained_VBD low_JJ ._SENT A_DT second_JJ vhs-deficient_JJ virus_NN ,_, 333-vhsB_JJ ,_, also_RB remained_VBD attenuated_VBN in_IN SCID_NN mice_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT These_DT results_NNS indicate_VBP that_IN adaptive_JJ immune_JJ responses_NNS were_VBD not_RB responsible_JJ for_IN the_DT reduced_VBN capacity_NN of_IN vhs-deficient_JJ virus_NN to_TO replicate_VB or_CC cause_VB disease_NN and_CC ,_, thus_RB ,_, that_DT vhs_NNS does_VBZ not_RB play_VB a_DT significant_JJ role_NN in_IN counteracting_VBG the_DT adaptive_JJ immune_JJ response_NN during_IN acute_JJ infection_NN ._SENT SCID_NN mice_NNS lack_VBP T_NN and_CC B_NN lymphocytes_NNS ,_, but_CC they_PP possess_VBP normal_JJ innate_JJ immune_JJ mechanisms_NNS ._SENT A_DT key_JJ mediator_NN of_IN innate_JJ antiviral_JJ responses_NNS is_VBZ IFN-alpha/beta_NP ._SENT Although_IN vhs_NNS of_IN HSV-1_NP does_VBZ not_RB appear_VB to_TO influence_VB IFN-mediated_JJ antiviral_JJ resistance_NN in_IN vivo_JJ ,_, three_CD observations_NNS suggested_VBD that_IN HSV-2_NP may_MD utilize_VB vhs_NNS to_TO counteract_VB the_DT IFN-alpha/beta_NP response_NN ._SENT IFN_NN sensitivity_NN of_IN a_DT wild-type_JJ HSV-2_NP strain_NN has_VBZ been_VBN mapped_VBN to_TO a_DT region_NN that_WDT includes_VBZ the_DT vhs_NNS locus_NN ,_, a_DT UL13-_NP HSV-2_NP strain_NN with_IN reduced_VBN vhs_NNS activity_NN permits_VBZ more_JJR IFN_NP production_NN in_IN vivo_JJ ,_, and_CC HSV-2_NP vhs_NNS activity_NN is_VBZ much_RB stronger_JJR and_CC faster_JJR than_IN that_DT of_IN HSV-1_NP ._SENT We_PP therefore_RB examined_VBD the_DT pathogenesis_NN of_IN vhs-deficient_JJ HSV-2_NP strains_NNS in_IN mice_NNS genetically_RB deficient_JJ in_IN the_DT receptor_NN for_IN all_DT IFN-alpha/beta_NP (_( IFN-alpha/betaR-/-_NP )_) ._SENT IFN-alpha/betaR-/-_NN and_CC wild-type_NN 129_CD mice_NNS were_VBD infected_VBN i.vag_NN ._SENT with_IN 2_CD x_SYM 106_CD PFU_NP of_IN 333_CD (_( clone_NN SB5_NP )_) ,_, 333d41_JJ ,_, or_CC vhs_NNS rescue_NN virus_NN 333d41R_NN ._SENT In_IN 129_CD mice_NNS ,_, 333d41_JJ replicated_VBD approximately_RB 100-fold_NN less_RBR efficiently_RB in_IN the_DT genital_JJ mucosa_NN at_IN all_DT time_NN points_NNS compared_VBN to_TO wild-type_NN and_CC vhs_NNS rescue_NN viruses_NNS ._SENT In_IN IFN-alpha/betaR-/-_NN mice_NNS ,_, replication_NN profiles_NNS of_IN SB5_NP and_CC 333d41R_NP were_VBD similar_JJ to_TO those_DT seen_VBN in_IN wild-type_NN 129_CD mice_NNS over_IN the_DT first_JJ 2_CD days_NNS postinfection_NN but_CC were_VBD maintained_VBN at_IN higher_JJR levels_NNS thereafter_RB ._SENT Strikingly_RB ,_, titers_NNS of_IN vhs-deficient_JJ 333d41_JJ were_VBD increased_VBN 20-_CD to_TO 50-fold_NN at_IN all_DT time_NN points_NNS in_IN IFN-alpha/betaR-/-_NN mice_NNS compared_VBN with_IN 129_CD mice_NNS (_( P_NN <_SYM 0.0001_CD )_) ._SENT Levels_NNS of_IN 333d41_JJ replication_NN in_IN IFN-alpha/betaR-/-_NP mice_NNS were_VBD not_RB statistically_RB different_JJ from_IN levels_NNS of_IN wild-type_NN and_CC rescue_NN viruses_NNS over_IN the_DT first_JJ 2_CD days_NNS postinfection_NN ._SENT These_DT data_NNS indicate_VBP a_DT significant_JJ recovery_NN of_IN replication_NN by_IN vhs-deficient_JJ virus_NN in_IN the_DT vaginal_JJ mucosa_NN of_IN mice_NNS lacking_VBG the_DT capacity_NN to_TO mount_VB an_DT IFN-alpha/beta-mediated_JJ antiviral_JJ response_NN ._SENT 333-vhsB_JJ was_VBD slightly_RB more_RBR attenuated_JJ than_IN 333d41_JJ in_IN 129_CD mice_NNS but_CC also_RB showed_VBD significantly_RB enhanced_JJ replication_NN in_IN the_DT genital_JJ mucosa_NN of_IN IFN-alpha/betaR-/-_NP mice_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Signs_NNS of_IN genital_JJ disease_NN in_IN 129_CD mice_NNS infected_VBN with_IN wild-type_NN and_CC vhs_NNS rescue_NN viruses_NNS became_VBD readily_RB apparent_JJ by_IN 4_CD days_NNS postinfection_NN and_CC were_VBD severe_JJ 5_CD to_TO 6_CD days_NNS postinfection_NN ._SENT Most_JJS mice_NNS developed_VBD hind_JJ limb_NN paralysis_NN by_IN day_NN 6_CD postinfection_NN ._SENT The_DT disease_NN course_NN in_IN IFN-alpha/betaR-/-_NP mice_NNS infected_VBN with_IN SB5_NP or_CC 333d41R_NP was_VBD similar_JJ to_TO that_DT in_IN 129_CD mice_NNS ,_, although_IN accelerated_VBN by_IN approximately_RB 1_CD day_NN ._SENT Whereas_IN infection_NN of_IN 129_CD mice_NNS with_IN vhs-deficient_JJ virus_NN had_VBD resulted_VBN in_IN mild_JJ genital_JJ inflammation_NN ,_, IFN-alpha/betaR-/-_NP mice_NNS showed_VBD severe_JJ genital_JJ disease_NN (_( P_NN =_SYM 0.013_CD and_CC 0.001_CD on_IN days_NNS 5_CD and_CC 6_CD ,_, respectively_RB )_) that_WDT developed_VBD with_IN approximately_RB the_DT same_JJ kinetics_NN as_IN disease_NN caused_VBN by_IN wild-type_NN and_CC vhs_NNS rescue_NN viruses_NNS ._SENT Furthermore_RB ,_, signs_NNS of_IN neurologic_JJ disease_NN were_VBD equally_RB apparent_JJ in_IN IFN-alpha/betaR-/-_NP mice_NNS infected_VBN with_IN vhs-deficient_NN ,_, wild-type_NN ,_, or_CC vhs_NNS rescue_NN viruses_NNS ._SENT These_DT data_NNS indicate_VBP that_IN the_DT virulence_NN of_IN vhs-deficient_JJ virus_NN is_VBZ markedly_RB increased_VBN in_IN IFN-alpha/betaR-/-_NP mice_NNS relative_JJ to_TO that_DT in_IN wild-type_NN virus_NN ._SENT At_IN 6_CD days_NNS postinfection_NN ,_, the_DT titers_NNS of_IN 333d41_JJ were_VBD significantly_RB lower_JJR than_IN those_DT of_IN wild-type_NN and_CC vhs_NNS rescue_NN viruses_NNS in_IN spinal_JJ cord_NN and_CC brainstem_NN and_CC could_MD not_RB be_VB detected_VBN in_IN the_DT brain_NN of_IN 129_CD mice_NNS ._SENT In_IN contrast_NN ,_, 333d41_JJ replicated_VBD to_TO levels_NNS equivalent_JJ to_TO wild-type_NN and_CC rescue_NN viruses_NNS in_IN the_DT spinal_JJ cord_NN and_CC brainstem_NN of_IN IFN-alpha/betaR-/-_NP mice_NNS (_( Fig._NN ;_: P_NN <_SYM 0.0001_CD compared_VBN to_TO 129_CD mice_NNS for_IN both_DT tissues_NNS )_) ._SENT Only_RB the_DT brain_NN contained_VBD lower_JJR titers_NNS of_IN 333d41_JJ than_IN the_DT wild-type_NN and_CC rescue_NN viruses_NNS ._SENT Thus_RB ,_, replication_NN of_IN vhs-deficient_JJ virus_NN is_VBZ largely_RB restored_VBN in_IN the_DT nervous_JJ systems_NNS of_IN IFN-alpha/betaR-/-_NN mice_NNS ._SENT We_PP observed_VBD in_IN these_DT experiments_NNS that_IN the_DT 333d41R_JJ virus_NN had_VBD a_DT slightly_RB less_RBR virulent_JJ phenotype_NN than_IN the_DT wild-type_JJ 333_CD derivative_JJ SB5_NP ._SENT Specifically_RB ,_, development_NN of_IN genital_JJ disease_NN was_VBD moderately_RB delayed_VBN in_IN IFN-alpha/betaR-/-_NP mice_NNS ,_, and_CC titers_NNS of_IN 333d41R_NP were_VBD lower_JJR than_IN those_DT of_IN SB5_NP in_IN the_DT brains_NNS of_IN 129_CD mice_NNS (_( P_NN =_SYM 0.005_CD )_) ._SENT 333d41R_NP possesses_VBZ wild-type_NN vhs_NNS activity_NN ,_, as_RB determined_VBN by_IN degradation_NN of_IN cellular_JJ glyceraldehyde-3-phosphate_NN dehydrogenase_NN mRNA_NN (_( data_NNS not_RB shown_VBN )_) ._SENT 333-vhsB_JJ ,_, 333d41_JJ ,_, and_CC 333d41R_JJ viruses_NNS were_VBD constructed_VBN from_IN wild-type_JJ HSV-2_NP strain_NN 333_CD ,_, whereas_IN SB5_NP is_VBZ a_DT clonal_JJ isolate_NN of_IN 333_CD ._SENT It_PP is_VBZ possible_JJ that_IN a_DT subtle_JJ difference_NN in_IN the_DT virulence_NN of_IN 333_CD and_CC SB5_NP exists_VBZ ,_, perhaps_RB due_JJ to_TO clonal_JJ selection_NN or_CC different_JJ passage_NN histories_NNS ._SENT Alternatively_RB ,_, a_DT secondary_JJ mutation_NN could_MD have_VB arisen_VBN in_IN the_DT construction_NN of_IN the_DT 333d41R_JJ virus_NN ._SENT In_IN preliminary_JJ studies_NNS ,_, 333-vhsBR_NP ,_, a_DT different_JJ rescue_NN virus_NN which_WDT replicates_VBZ like_IN SB5_NP in_IN the_DT cornea_NN ,_, was_VBD equivalent_JJ to_TO 333d41R_JJ in_IN the_DT genital_JJ model_NN (_( data_NNS not_RB shown_VBN )_) ._SENT This_DT result_NN suggests_VBZ that_IN 333d41R_NP does_VBZ not_RB contain_VB an_DT additional_JJ attenuating_NN mutation_NN relative_JJ to_TO 333-vhsB_JJ and_CC ,_, instead_RB ,_, it_PP implies_VBZ that_IN a_DT difference_NN in_IN the_DT pathogenicity_NN of_IN SB5_NP and_CC 333_CD is_VBZ discriminated_VBN in_IN the_DT vaginal_JJ model_NN of_IN HSV_NP infection_NN ._SENT We_PP have_VBP taken_VBN the_DT conservative_JJ approach_NN of_IN comparing_VBG 333d41_JJ to_TO the_DT 333d41R_JJ rescue_NN virus_NN rather_RB than_IN to_TO SB5_NP to_TO evaluate_VB statistical_JJ significance_NN of_IN differences_NNS resulting_VBG from_IN the_DT vhs_NNS mutation_NN ._SENT To_TO rigorously_RB demonstrate_VB vhs-specific_JJ phenotypic_JJ restoration_NN of_IN HSV-2_NP vhs_NNS mutants_NNS in_IN IFN-alpha/betaR-/-_NN mice_NNS ,_, groups_NNS of_IN 129_CD and_CC IFN-alpha/betaR-/-_NP mice_NNS were_VBD infected_VBN with_IN a_DT 333_CD strain_NN containing_VBG a_DT deletion_NN in_IN the_DT tk_NN gene_NN ,_, HSV-2_NP DeltaTK-_NP ._SENT tk_NN is_VBZ dispensable_JJ for_IN HSV_NP replication_NN in_IN dividing_VBG cells_NNS but_CC not_RB in_IN neurons_NNS ,_, and_CC tk-deficient_JJ viruses_NNS are_VBP less_RBR virulent_JJ than_IN wild-type_NN virus_NN ._SENT As_IN expected_VBN ,_, replication_NN of_IN DeltaTK-_NP in_IN the_DT genital_JJ mucosa_NN of_IN 129_CD mice_NNS and_CC IFN-alpha/betaR-/-_NN mice_NNS was_VBD equivalent_JJ to_TO that_DT of_IN wild-type_NN and_CC rescue_NN viruses_NNS ,_, and_CC genital_JJ inflammation_NN in_IN 129_CD mice_NNS was_VBD mild_JJ ._SENT In_IN distinct_JJ contrast_NN to_TO 333d41_JJ ,_, the_DT virulence_NN of_IN DeltaTK-_NP in_IN IFN-alpha/betaR-/-_NP mice_NNS was_VBD not_RB restored_VBN to_TO wild-type_NN levels_NNS ,_, and_CC DeltaTK-_NP could_MD be_VB detected_VBN only_RB at_IN low_JJ levels_NNS in_IN the_DT nervous_JJ systems_NNS of_IN IFN-alpha/betaR-/-_NN mice_NNS ._SENT These_DT observations_NNS indicate_VBP that_IN the_DT enhanced_JJ capacity_NN of_IN 333d41_JJ to_TO replicate_VB and_CC cause_VB disease_NN in_IN IFN-alpha/betaR-/-_NP mice_NNS was_VBD specific_JJ to_TO the_DT vhs_NNS lesion_NN ._SENT Another_DT criterion_NN of_IN specificity_NN for_IN viral_JJ inhibitors_NNS of_IN host_NN proteins_NNS involved_VBN in_IN key_JJ antiviral_JJ pathways_NNS is_VBZ the_DT demonstration_NN that_IN recovery_NN of_IN virulence_NN occurs_VBZ only_RB in_IN the_DT absence_NN of_IN the_DT particular_JJ host_NN protein_NN ._SENT This_DT criterion_NN may_MD be_VB difficult_JJ to_TO meet_VB for_IN a_DT viral_JJ protein_NN such_JJ as_IN vhs_NNS that_WDT likely_RB employs_VBZ the_DT relatively_RB nonspecific_JJ mechanism_NN of_IN mRNA_NN degradation_NN to_TO block_VB host_NN antiviral_JJ responses_NNS ._SENT To_TO begin_VB to_TO dissect_VB IFN-stimulated_JJ antiviral_JJ pathways_NNS inhibited_VBN by_IN vhs_NNS ,_, as_RB well_RB as_RB to_TO evaluate_VB specificity_NN ,_, we_PP focused_VBD on_IN PKR_NP ._SENT PKR_NP ,_, one_CD of_IN the_DT best-characterized_JJ IFN-alpha/beta-stimulated_JJ genes_NNS ,_, directs_VBZ the_DT shutoff_NN of_IN host_NN cell_NN protein_NN synthesis_NN ._SENT We_PP investigated_VBD the_DT role_NN of_IN HSV-2_JJ vhs_NNS in_IN inhibition_NN of_IN the_DT PKR_NP pathway_NN by_IN using_VBG mice_NNS that_WDT lack_VBP PKR_NP (_( PKR-/-_NP )_) ._SENT Interestingly_RB ,_, we_PP found_VBD that_DT replication_NN in_IN the_DT genital_JJ mucosa_NN and_CC virulence_NN of_IN 333d41_JJ were_VBD not_RB restored_VBN in_IN PKR-/-_NP mice_NNS relative_JJ to_TO wild-type_NN virus_NN ._SENT Titers_NNS of_IN vhs-deficient_JJ virus_NN were_VBD higher_JJR in_IN PKR-/-_JJ mice_NNS than_IN in_IN wild-type_NN 129_CD mice_NNS only_RB in_IN the_DT spinal_JJ cord_NN (_( Fig._NN ;_: P_NN =_SYM 0.0016_CD )_) ._SENT The_DT PKR-deficient_JJ phenotype_NN of_IN PKR-/-_NP mice_NNS was_VBD confirmed_VBN by_IN the_DT capacity_NN to_TO restore_VB replication_NN of_IN the_DT gamma34.5-deficient_JJ HSV-1_JJ strain_NN ,_, 17termA_NP (_( data_NN not_RB shown_VBN )_) ._SENT These_DT results_NNS indicate_VBP that_IN vhs_NN does_VBZ not_RB counteract_VB the_DT antiviral_JJ activities_NNS of_IN PKR_NP and_CC that_DT restoration_NN of_IN replication_NN and_CC virulence_NN of_IN vhs-deficient_JJ virus_NN is_VBZ not_RB a_DT universal_JJ phenomenon_NN in_IN mice_NNS with_IN genetic_JJ defects_NNS (_( even_RB defects_NNS in_IN a_DT specific_JJ IFN-alpha/beta-induced_JJ antiviral_JJ pathway_NN )_) ._SENT vhs_NNS instead_RB must_MD interfere_VB with_IN a_DT separate_JJ antiviral_JJ mechanism_NN stimulated_VBN by_IN IFN-alpha/betaR_NP engagement_NN ._SENT vhs-deficient_NP HSV-1_NP does_VBZ not_RB regain_VB the_DT capacity_NN to_TO replicate_VB and_CC cause_VB disease_NN in_IN the_DT corneas_NNS of_IN IFN-alpha/betaR-/-_NN mice_NNS ,_, indicating_VBG that_IN HSV-1_JJ vhs_NNS is_VBZ not_RB an_DT inhibitor_NN of_IN the_DT IFN-alpha/beta_NP response_NN in_IN the_DT eye_NN ._SENT We_PP therefore_RB investigated_VBD whether_IN a_DT unique_JJ property_NN of_IN genital_JJ epithelial_JJ cells_NNS or_CC of_IN HSV-2_JJ vhs_NNS resulted_VBN in_IN HSV-2_JJ interference_NN with_IN the_DT IFN-alpha/beta_NP response_NN in_IN the_DT genital_JJ tract_NN ._SENT As_IN shown_VBN in_IN Fig._NN ,_, the_DT HSV-1_JJ vhs_NNS null_JJ mutant_JJ UL41NHB_NN did_VBD not_RB replicate_VB efficiently_RB in_IN the_DT genital_JJ mucosa_NN of_IN 129_CD mice_NNS after_IN i.vag_NN ._SENT inoculation_NN ._SENT Titers_NNS of_IN UL41NHB_NP were_VBD only_RB slightly_RB elevated_VBN in_IN IFN-alpha/betaR-/-_NP mice_NNS and_CC were_VBD not_RB increased_VBN relative_JJ to_TO those_DT of_IN wild-type_NP HSV-1_NP ._SENT Virulence_NN of_IN wild-type_NN virus_NN was_VBD enhanced_VBN by_IN infection_NN of_IN IFN-alpha/betaR-/-_NP mice_NNS ,_, but_CC vhs-deficient_NP HSV-1_NP remained_VBD attenuated_JJ ._SENT Neither_DT virus_NN was_VBD detectable_JJ in_IN the_DT nervous_JJ system_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Thus_RB ,_, recovery_NN of_IN a_DT vhs_NNS mutant_NN 's_POS capacity_NN to_TO replicate_VB and_CC cause_VB disease_NN similar_JJ to_TO wild-type_NN virus_NN in_IN the_DT absence_NN of_IN an_DT IFN-alpha/beta_NP response_NN is_VBZ unique_JJ to_TO HSV-2_JJ vhs_NNS and_CC is_VBZ not_RB a_DT general_JJ property_NN of_IN the_DT i.vag_NN ._SENT route_NN of_IN infection_NN ._SENT The_DT vhs_NNS protein_NN clearly_RB contributes_VBZ to_TO HSV_NP virulence_NN in_IN the_DT host_NN ,_, because_IN vhs-deficient_JJ mutants_NNS of_IN HSV_NP are_VBP highly_RB attenuated_VBN in_IN various_JJ mouse_NN models_NNS of_IN HSV_NP infection_NN ._SENT One_CD hundred-_NN to_TO 1,000-fold_NN less_JJR replication_NN occurs_VBZ in_IN the_DT genital_JJ mucosa_NN after_IN infection_NN with_IN vhs-deficient_JJ HSV-2_NP ,_, and_CC little_JJ virus_NN reaches_VBZ the_DT nervous_JJ system_NN ._SENT We_PP have_VBP made_VBN several_JJ observations_NNS regarding_VBG the_DT role_NN of_IN HSV-2_JJ vhs_NNS in_IN pathogenesis_NN that_WDT largely_RB explain_VBP the_DT attenuation_NN of_IN vhs-deficient_JJ viruses_NNS ._SENT First_RB ,_, we_PP determined_VBD that_IN adaptive_JJ immunity_NN is_VBZ not_RB responsible_JJ for_IN attenuation_NN of_IN vhs-deficient_JJ HSV-2_NP or_CC HSV-1_NP during_IN acute_JJ infection_NN by_IN demonstrating_VBG that_IN the_DT mutant_JJ viruses_NNS remain_VBP attenuated_VBN during_IN primary_JJ infection_NN of_IN SCID_NN mice_NNS ._SENT Second_RB ,_, we_PP have_VBP shown_VBN that_DT vhs_NNS interferes_VBZ with_IN an_DT aspect(s)_NN of_IN the_DT IFN-alpha/beta_NP response_NN ,_, because_IN replication_NN and_CC especially_RB virulence_NN of_IN vhs-deficient_JJ HSV-2_NP are_VBP significantly_RB increased_VBN relative_JJ to_TO wild-type_NN and_CC rescue_NN viruses_NNS in_IN IFN-alpha/betaR-/-_NN mice_NNS ._SENT Third_JJ ,_, inhibition_NN of_IN the_DT IFN-alpha/beta_NP response_NN is_VBZ a_DT unique_JJ property_NN of_IN the_DT HSV-2_NP vhs_NNS protein_NN ,_, because_IN vhs-deficient_JJ HSV-1_JJ replication_NN and_CC virulence_NN do_VBP not_RB improve_VB relative_JJ to_TO wild-type_VB HSV-1_NP after_IN i.vag_NP ._SENT (_( Fig._NN to_TO )_) or_CC corneal_JJ infection_NN of_IN IFN-alpha/betaR-/-_NP mice_NNS ._SENT Fourth_JJ ,_, vhs_NN does_VBZ not_RB assist_VB HSV-2_JJ evasion_NN of_IN the_DT IFN-alpha/beta_NP response_NN by_IN interfering_VBG with_IN the_DT PKR_NP pathway_NN ._SENT The_DT IFN-alpha/beta_NP response_NN rapidly_RB constructs_VBZ a_DT formidable_JJ barrier_NN to_TO virus_NN infection_NN ;_: the_DT dramatic_JJ effect_NN of_IN IFN-alpha/beta_NP on_IN the_DT pathogenesis_NN of_IN a_DT virus_NN without_IN vhs_NNS as_IN a_DT countermeasure_NN attests_VBZ to_TO the_DT significance_NN of_IN HSV-2_JJ vhs_NNS as_IN a_DT modulator_NN of_IN this_DT innate_JJ host_NN defense_NN mechanism_NN ._SENT In_IN order_NN to_TO prove_VB specificity_NN in_IN the_DT restoration_NN of_IN the_DT wild-type_NN phenotype_NN to_TO vhs-deficient_JJ viruses_NNS in_IN IFN-alpha/betaR-/-_NN mice_NNS ,_, it_PP was_VBD important_JJ to_TO demonstrate_VB that_IN (_( i_NP )_) an_DT attenuated_JJ viral_JJ strain_NN with_IN a_DT mutation_NN in_IN a_DT gene_NN irrelevant_JJ to_TO IFN-alpha/beta_NP remains_VBZ attenuated_VBN in_IN IFN-alpha/betaR-/-_NP mice_NNS ,_, and_CC (_( ii_NNS )_) the_DT vhs_NNS mutant_JJ virus_NN is_VBZ not_RB restored_VBN in_IN a_DT host_NN with_IN a_DT different_JJ genetic_JJ lesion_NN ._SENT We_PP have_VBP satisfied_VBN the_DT first_JJ of_IN these_DT specificity_NN criteria_NNS with_IN the_DT tk-_NN mutant_JJ virus_NN ,_, DeltaTK-_NP ._SENT We_PP observed_VBD that_IN DeltaTK-_NP replicated_VBD poorly_RB in_IN the_DT nervous_JJ systems_NNS of_IN 129_CD mice_NNS and_CC ,_, unlike_IN 333d41_JJ ,_, did_VBD not_RB replicate_VB well_RB in_IN the_DT nervous_JJ systems_NNS of_IN IFN-alpha/betaR-/-_NN mice_NNS ,_, even_RB with_IN an_DT inoculum_NN of_IN 2_CD x_SYM 106_CD PFU_NP ._SENT Therefore_RB ,_, restoration_NN was_VBD specific_JJ to_TO the_DT vhs_NNS mutation_NN ._SENT Leib_NP et_FW al._FW observed_VBD that_IN a_DT tk-_NN HSV-1_JJ mutant_NN inoculated_VBN at_IN the_DT same_JJ dose_NN replicated_VBN more_RBR efficiently_RB in_IN the_DT corneal_JJ epithelium_NN of_IN IFN-alpha/beta/gammaR-/-_NP mice_NNS than_IN wild-type_NN mice_NNS but_CC was_VBD barely_RB detectable_JJ in_IN the_DT nervous_JJ system_NN through_IN 5_CD days_NNS postinfection_NN ._SENT Taken_VBN together_RB ,_, these_DT data_NNS suggest_VBP that_IN loss_NN of_IN alpha/beta_NP or_CC alpha/beta/gamma_NP IFN_NP receptors_NNS does_VBZ not_RB globally_RB restore_VB the_DT capacity_NN of_IN HSV_NP mutants_NNS to_TO replicate_VB in_IN the_DT nervous_JJ system_NN ._SENT Infection_NN of_IN PKR-/-_NP mice_NNS satisfied_VBD the_DT second_JJ criterion_NN for_IN specificity_NN in_IN that_DT 333d41_JJ was_VBD not_RB restored_VBN for_IN replication_NN or_CC virulence_NN ._SENT While_IN the_DT PKR_NP mutation_NN is_VBZ not_RB independent_JJ of_IN the_DT IFN-alpha/beta_NP receptor_NN signaling_VBG pathway_NN ,_, our_PP$ data_NNS indicate_VBP that_IN this_DT separate_JJ host_NN genetic_JJ mutation_NN does_VBZ not_RB restore_VB vhs-deficient_JJ viruses_NNS to_TO virulence_NN and_CC ,_, therefore_RB ,_, restoration_NN is_VBZ specific_JJ to_TO the_DT IFN-alpha/betaR_NP mutation_NN ._SENT The_DT fact_NN that_IN attenuation_NN of_IN 333d41_JJ was_VBD not_RB reversed_VBN by_IN deletion_NN of_IN the_DT host_NN PKR_NN gene_NN is_VBZ intriguing_JJ ._SENT This_DT result_NN suggests_VBZ that_IN although_IN PKR_NP mediates_VBZ an_DT important_JJ antiviral_JJ pathway_NN that_WDT is_VBZ induced_VBN by_IN IFN-alpha/betaR_NP engagement_NN ,_, PKR_NP is_VBZ not_RB the_DT primary_JJ target_NN of_IN vhs-mediated_JJ host_NN inhibition_NN ._SENT HSV_NP already_RB encodes_VBZ two_CD proteins_NNS ,_, US11_NP and_CC ICP34.5_NP ,_, demonstrated_VBD to_TO block_VB PKR-mediated_JJ protein_NN synthesis_NN inhibition_NN at_IN different_JJ stages_NNS ._SENT With_IN two_CD specific_JJ inhibitors_NNS of_IN the_DT PKR_NP pathway_NN ,_, it_PP may_MD not_RB be_VB necessary_JJ for_IN HSV_NP to_TO encode_VB yet_RB another_DT inhibitor_NN ._SENT Lack_NN of_IN PKR_NP pathway_NN disruption_NN also_RB suggests_VBZ that_IN vhs_NNS may_MD discriminately_RB inhibit_VB host_NN antiviral_JJ functions_NNS ._SENT However_RB ,_, if_IN vhs_NNS utilizes_VBZ its_PP$ RNase_NP activity_NN to_TO inhibit_VB inducible_JJ mediators_NNS of_IN the_DT IFN-alpha/beta_NP response_NN ,_, it_PP may_MD have_VB a_DT limited_JJ capacity_NN to_TO block_VB the_DT PKR_NP pathway_NN due_JJ to_TO preformed_JJ PKR_NN in_IN cells_NNS that_WDT can_MD be_VB directly_RB activated_VBN by_IN virus_NN infection_NN ._SENT Determining_VBG which_WDT IFN-related_JJ antiviral_JJ pathways_NNS are_VBP opposed_VBN by_IN vhs_NNS and_CC the_DT mechanisms_NNS of_IN vhs_NNS action_NN will_MD be_VB the_DT focus_NN of_IN future_JJ experiments_NNS ._SENT If_IN the_DT mechanism_NN of_IN IFN-alpha/beta_NP pathway_NN inhibition_NN by_IN vhs_NNS does_VBZ involve_VB RNA_NP degradation_NN ,_, as_RB seems_VBZ likely_RB ,_, vhs_NNS could_MD be_VB unique_JJ as_IN a_DT general_NN ,_, relatively_RB nonspecific_JJ inhibitor_NN of_IN the_DT inducible_JJ IFN-alpha/beta_NP response_NN ._SENT In_IN this_DT manner_NN ,_, vhs_NNS could_MD be_VB broadly_RB useful_JJ to_TO the_DT virus_NN across_IN cell_NN types_NNS and_CC tissues_NNS that_WDT may_MD vary_VB in_IN their_PP$ dependence_NN on_IN individual_JJ IFN-induced_JJ antiviral_JJ pathways_NNS ._SENT Nevertheless_RB ,_, some_DT evidence_NN for_IN tissue_NN specificity_NN in_IN HSV-2_NP vhs_NNS interference_NN with_IN the_DT IFN-alpha/beta_NP response_NN may_MD have_VB arisen_VBN in_IN our_PP$ present_JJ experiments_NNS ._SENT Restoration_NN of_IN vhs-deficient_JJ HSV-2_NP replication_NN in_IN the_DT genital_JJ mucosa_NN of_IN IFN-alpha/betaR-/-_NP mice_NNS was_VBD not_RB comprehensive_JJ because_IN titers_NNS were_VBD lower_JJR than_IN those_DT for_IN wild-type_NN virus_NN at_IN 3_CD and_CC 4_CD days_NNS postinfection_NN ._SENT Despite_IN reduced_VBN mucosal_JJ replication_NN ,_, vhs-deficient_JJ virus_NN replicated_VBN as_RB vigorously_RB as_IN wild-type_NN virus_NN in_IN the_DT spinal_JJ cord_NN and_CC brainstem_NN ._SENT Thus_RB ,_, differences_NNS may_MD exist_VB in_IN the_DT particular_JJ antiviral_JJ pathways_NNS stimulated_VBN by_IN IFN-alpha/betaR_NP engagement_NN in_IN specific_JJ tissues_NNS ,_, and_CC some_DT of_IN these_DT pathways_NNS ,_, for_IN example_NN ,_, PKR_NP ,_, may_MD be_VB less_RBR inhibited_VBN by_IN vhs_NNS than_IN others_NNS ._SENT Such_JJ cell-type-specific_JJ differences_NNS in_IN IFN_NP induction_NN have_VBP been_VBN noted_VBN in_IN reovirus_NN infections_NNS of_IN cardiac_JJ myocytes_NNS versus_CC skeletal_JJ muscle_NN cells_NNS ._SENT In_IN the_DT genital_JJ mucosa_NN ,_, NK_JJ cells_NNS ,_, neutrophils_NNS ,_, or_CC even_RB early_JJ antiviral_JJ T-cell_NN responses_NNS may_MD also_RB help_VB reduce_VB vhs-deficient_JJ virus_NN replication_NN after_IN 48_CD h._NN We_PP are_VBP currently_RB investigating_VBG the_DT reason_NN for_IN the_DT later_JJR decline_NN in_IN vhs-deficient_JJ virus_NN titer_NN in_IN the_DT mucosa_NN of_IN IFN-alpha/betaR-/-_NP mice_NNS relative_JJ to_TO that_DT with_IN wild-type_NN virus_NN ._SENT Production_NN of_IN IFN-alpha/beta_NP and_CC IFN-stimulated_JJ gene_NN induction_NN in_IN the_DT genital_JJ mucosa_NN will_MD be_VB interesting_JJ areas_NNS of_IN future_JJ investigation_NN ._SENT Our_PP$ observation_NN that_IN HSV-2_NP vhs_NNS counteracts_VBZ the_DT IFN-alpha/beta_NP response_NN fits_VBZ logically_RB into_IN a_DT picture_NN of_IN HSV-2_JJ pathogenesis_NN for_IN three_CD reasons_NNS ._SENT First_RB ,_, vhs_NP enters_VBZ the_DT cytoplasm_NN with_IN the_DT infecting_VBG virion_NN and_CC ,_, thus_RB ,_, can_MD immediately_RB counter_VB rapid_JJ IFN_NP synthesis_NN or_CC receptor-mediated_JJ induction_NN of_IN the_DT antiviral_JJ state_NN ._SENT Indeed_RB ,_, IFN-alpha_NP can_MD suppress_VB immediate-early_JJ gene_NN expression_NN ,_, so_RB the_DT virus_NN must_MD have_VB an_DT immediate_JJ counterresponse_NN ._SENT Second_RB ,_, because_IN vhs_NNS degrades_VBZ mRNA_NN ,_, it_PP could_MD counteract_VB a_DT wide_JJ variety_NN of_IN host_NN responses_NNS essential_JJ to_TO induction_NN of_IN the_DT antiviral_JJ state_NN ,_, including_VBG IFN-beta_NP and_CC -alpha4_NP produced_VBD by_IN the_DT initially_RB infected_JJ cells_NNS ._SENT Finally_RB ,_, HSV-2_NP is_VBZ even_RB more_RBR resistant_JJ to_TO IFN-alpha/beta_NP than_IN HSV-1_NP ,_, and_CC HSV-2_NP vhs_NNS is_VBZ faster_JJR and_CC approximately_RB 40-fold_NN more_RBR active_JJ than_IN HSV-1_JJ vhs_NNS ._SENT An_DT effect_NN of_IN HSV-2_JJ vhs_NNS on_IN the_DT host_NN IFN-alpha/beta_NP response_NN therefore_RB should_MD be_VB more_RBR readily_RB discernible_JJ than_IN an_DT effect_NN of_IN HSV-1_JJ vhs_NNS ._SENT Our_PP$ results_NNS highlight_VB an_DT important_JJ difference_NN in_IN the_DT pathogenic_JJ mechanisms_NNS of_IN HSV-2_NP and_CC HSV-1_NP ._SENT We_PP observed_VBD that_IN the_DT presence_NN or_CC absence_NN of_IN functional_JJ lymphocytes_NNS emphatically_RB does_VBZ not_RB alter_VB the_DT pathogenesis_NN of_IN either_DT HSV-1_JJ (_( data_NNS not_RB shown_VBN )_) or_CC HSV-2_JJ vhs-deficient_JJ viruses_NNS in_IN a_DT naive_JJ host_NN ._SENT This_DT observation_NN indicates_VBZ that_IN the_DT adaptive_JJ immune_JJ response_NN is_VBZ not_RB responsible_JJ for_IN attenuating_VBG the_DT pathogenesis_NN of_IN viruses_NNS that_IN lack_NN vhs_NNS activity_NN ,_, at_IN least_JJS during_IN a_DT rapidly_RB progressing_VBG primary_JJ infection_NN in_IN BALB/c_NP mice_NNS ._SENT Because_IN the_DT IFN-alpha/betaR-/-_NP mice_NNS used_VBD had_VBD a_DT 129_CD genetic_JJ background_NN ,_, it_PP is_VBZ formally_RB possible_JJ that_IN vhs_NNS could_MD interfere_VB with_IN primary_JJ adaptive_JJ immune_JJ responses_NNS in_IN 129_CD mice_NNS ._SENT However_RB ,_, the_DT generally_RB greater_JJR resistance_NN of_IN 129_CD mice_NNS to_TO HSV_NP infection_NN should_MD make_VB recovery_NN of_IN virulence_NN by_IN vhs-deficient_JJ virus_NN more_RBR challenging_JJ ._SENT Despite_IN observations_NNS that_IN vhs_NN interferes_VBZ with_IN the_DT expression_NN of_IN MHC_NP class_NN I_PP and_CC class_VB II_NP molecules_NNS ,_, our_PP$ result_NN was_VBD not_RB entirely_RB surprising_JJ given_VBN that_IN replication_NN of_IN vhs-deficient_JJ viruses_NNS in_IN the_DT genital_JJ mucosa_NN of_IN wild-type_NN mice_NNS is_VBZ curtailed_VBN within_IN 48_CD h._NN Nevertheless_RB ,_, vhs_NNS could_MD play_VB a_DT role_NN in_IN adaptive_JJ immune_JJ responses_NNS during_IN reactivation_NN in_IN an_DT immune_JJ host_NN ,_, when_WRB evasion_NN of_IN memory_NN cytotoxic_JJ T-lymphocyte_NN responses_NNS would_MD confer_VB a_DT significant_JJ advantage_NN to_TO the_DT virus_NN ._SENT Our_PP$ results_NNS also_RB do_VBP not_RB preclude_VB the_DT possibility_NN that_IN vhs_NN retards_VBZ the_DT induction_NN of_IN adaptive_JJ immune_JJ responses_NNS through_IN its_PP$ interference_NN with_IN MHC_NP expression_NN and_CC potentially_RB through_IN its_PP$ inhibition_NN of_IN the_DT IFN-alpha/beta_NP response_NN ._SENT IFNs_NNS induce_VBP the_DT activation_NN and_CC maturation_NN of_IN dendritic_JJ cells_NNS ,_, the_DT most_RBS potent_JJ antigen-presenting_NN cell_NN type_NN for_IN naive_JJ T_NN cells_NNS ._SENT IFN-alpha/beta_NP thus_RB establishes_VBZ an_DT important_JJ link_NN between_IN early_JJ innate_JJ responses_NNS and_CC developing_VBG antiviral_JJ adaptive_JJ immunity_NN ._SENT If_IN less_JJR IFN-alpha/beta_NN is_VBZ produced_VBN by_IN wild-type_JJ virus-infected_JJ cells_NNS than_IN by_IN cells_NNS infected_VBN with_IN vhs-deficient_JJ virus_NN ,_, the_DT adaptive_JJ immune_JJ response_NN to_TO wild-type_NN virus_NN may_MD be_VB delayed_VBN or_CC reduced_VBN in_IN magnitude_NN ._SENT We_PP are_VBP currently_RB investigating_VBG this_DT possibility_NN ._SENT In_IN any_DT event_NN ,_, our_PP$ observation_NN that_IN vhs_NN counteracts_VBZ the_DT innate_JJ antiviral_JJ IFN-alpha/beta_NP response_NN during_IN acute_JJ infection_NN ,_, coupled_VBN with_IN its_PP$ capacity_NN to_TO down-regulate_VB MHC_NP molecules_NNS crucial_JJ in_IN adaptive_JJ immune_JJ responses_NNS ,_, mark_NN vhs_NNS as_IN a_DT multifunctional_JJ immune_JJ evasion_NN mechanism_NN of_IN HSV-2_NP ._SENT Pathogenesis_NN of_IN vhs-deficient_JJ HSV-2_NP is_VBZ not_RB restored_VBN in_IN SCID_NN mice_NNS ._SENT Pathogenesis_NN of_IN vhs-deficient_JJ HSV-2_NP is_VBZ not_RB restored_VBN in_IN SCID_NN mice_NNS ._SENT Groups_NNS of_IN four_CD BALB/c_NP and_CC congenic_JJ CB.17-SCID_NP mice_NNS were_VBD infected_VBN i.vag_NN ._SENT with_IN 2_CD x_SYM 106_CD PFU_NN of_IN vhs-deficient_JJ HSV-2_NP ,_, strain_NN 333d41_JJ ,_, or_CC the_DT vhs_NNS rescue_NN virus_NN 333d41R_NP ._SENT (_( A_NP )_) Replication_NN in_IN the_DT genital_JJ mucosa_NN of_IN BALB/c_NP and_CC SCID_NN mice_NNS ._SENT The_DT titer_NN of_IN virus_NN in_IN vaginal_JJ swab_NN samples_NNS was_VBD determined_VBN by_IN standard_JJ plaque_NN assay_NN ._SENT Data_NP points_NNS represent_VBP the_DT geometric_JJ mean_JJ +-_NN standard_JJ error_NN of_IN the_DT mean_JJ (_( SEM_NP )_) ._SENT (_( B_NP )_) Severity_NP of_IN genital_JJ and_CC neurological_JJ disease_NN in_IN BALB/c_NP and_CC SCID_NN mice_NNS ._SENT Mice_NNS were_VBD scored_VBN for_IN signs_NNS of_IN disease_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Values_NNS represent_VBP the_DT arithmetic_JJ mean_JJ +-_NN SEM_NP ._SENT (_( C_NP )_) Replication_NN in_IN the_DT nervous_JJ systems_NNS of_IN BALB/c_NP and_CC SCID_NN mice_NNS ._SENT Mice_NNS were_VBD sacrificed_VBN 6_CD d_SYM postinfection_NN ._SENT Brain_NN ,_, brainstem_NN ,_, and_CC spinal_JJ cord_NN tissues_NNS were_VBD disru_NN 